IgG‐Bridging–Seeded Synergistic Aggregation of SARS‐CoV‐2 Spikes Underlies Potent Neutralization by a Low‐Affinity Antibody
Advanced Science · 2025
DOI: 10.1002/advs.202517192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Niannian Lv und 29 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Col…. Hauptthemen laut MEDLINE: SARS-CoV-2, Immunoglobulin G, Spike Glycoprotein, Coronavirus, Antibodies, Neutralizing. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Beijing Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Mechanistic studies of viral neutralization typically prioritize high‐affinity antibodies, relegating low‐affinity binders to the sidelines. P5‑1C8, a Class 1 SARS‐CoV‐2 antibody that exemplifies this underexplored “low‑affinity yet high‑potency” phenotype is reported, retaining strong neutralization of Omicron JN.1 despite markedly weakened trimer binding (K D = 225 nM; IC 50 = 0.06 nM). Structural and biophysical analyses reveal that P5‐1C8 engages WT and BA.1 spikes through canonical intra‐spike bivalency, but with JN.1 it induces aggregation. Using virion‐like nanoparticles displaying multiple spikes, it is shown that IgG remains bound with no detectable dissociation and triggers pronounced aggregation. Coarse‐grained molecular dynamics delineate the stepwise pathway in which weak IgG‐spike contacts seed aggregation via transient inter‐spike bridging. Together, these findings establish the first mechanistic framework demonstrating how weak‐binding antibodies can nonetheless achieve potent neutralization through higher‐order aggregation, thereby expanding the conceptual landscape of antibody function and opening new directions for antibody evaluation and design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
- Laboratory of Nanosystem and Hierarchical Fabrication, National Center for Nanoscience and Technology, Beijing, 100190, China.
- Research Unit of Nanoscience and Technology, Chinese Academy of Medical Sciences, Beijing, 100730, China.
- Comprehensive AIDS Research Center, Pandemic Research Alliance Unit, Center for Infection Biology, School of Basic Medical Sciences, Tsinghua University, Beijing, 100084, China.
- State Key Laboratory of Chemical Engineering and Low-carbon Technology, Department of Chemical Engineering and Low-carbon Technology, Tsinghua University, Beijing, 100084, China.
- CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Chinese Academy of Sciences, Beijing, 100190, China.
ORCID-Profile: Niannian Lv, Zhihua Liu, Li-Tang Yan, Yuhe Renee Yang
Förderung
- National Key R&D Program of China
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- Strategic Priority Research Program of Chinese Academy of Sciences
- CAMS Innovation Fund for Medical Sciences
- National Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Lv, N., Chen, P., Dai, X., Xu, H., Li, Z., Shan, Z., Li, J., Guo, F., Chen, Y., Li, J., Huang, Y., Dong, G., Jiang, Y., Chen, L., Nan, X., Zhao, H., Zhang, K., Fan, S., Dong, Y., …, & Yang, Y. R. (2025). IgG‐Bridging–Seeded Synergistic Aggregation of SARS‐CoV‐2 Spikes Underlies Potent Neutralization by a Low‐Affinity Antibody. Advanced Science. https://doi.org/10.1002/advs.202517192
Vancouver
Lv N, Chen P, Dai X, Xu H, Li Z, Shan Z, et al. IgG‐Bridging–Seeded Synergistic Aggregation of SARS‐CoV‐2 Spikes Underlies Potent Neutralization by a Low‐Affinity Antibody. Advanced Science. 2025. doi:10.1002/advs.202517192
BibTeX
@article{Lv2025,
author = {Lv, Niannian and Chen, Peng and Dai, Xiaobin and Xu, Hu and Li, Ziheng and Shan, Zelin and Li, Jinqian and Guo, Fenglin and Chen, Yuanfang and Li, Jiayi and Huang, Yiqian and Dong, Guizhi and Jiang, Yifan and Chen, Liang and Nan, Xuanyu and Zhao, Hanjun and Zhang, Kang and Fan, Shilong and Dong, Yuanchen and Liu, Dongsheng and Wang, Xinquan and Huang, Deli and Pan, Xiaojing and Chen, Chunying and Liu, Zhihua and Yan, Li-Tang and Zhang, Qi and Zhang, Linqi and Zhao, Yuliang and Yang, Yuhe Renee},
title = {IgG‐Bridging–Seeded Synergistic Aggregation of SARS‐CoV‐2 Spikes Underlies Potent Neutralization by a Low‐Affinity Antibody},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202517192}
}
EUVIMED